vimarsana.com

Latest Breaking News On - Zynerba pharmaceuticals company profile - Page 1 : vimarsana.com

StockNews com Begins Coverage on Zynerba Pharmaceuticals (NASDAQ:ZYNE)

StockNews.com began coverage on shares of Zynerba Pharmaceuticals (NASDAQ:ZYNE – Free Report) in a research report released on Friday. The firm issued a sell rating on the stock. Several other brokerages have also recently weighed in on ZYNE. HC Wainwright cut Zynerba Pharmaceuticals from a buy rating to a neutral rating in a report on […]

Bernardo Wealth Planning LLC Buys 40,000 Shares of Zynerba Pharmaceuticals, Inc (NASDAQ:ZYNE)

Bernardo Wealth Planning LLC boosted its stake in shares of Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE – Free Report) by 103.7% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 78,578 shares of the company’s stock after acquiring an additional 40,000 shares during the […]

Zynerba Pharmaceuticals, Inc (NASDAQ:ZYNE) President Sells $16,493 33 in Stock

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE – Get Free Report) President Terri B. Sebree sold 12,401 shares of the company’s stock in a transaction dated Wednesday, September 13th. The stock was sold at an average price of $1.33, for a total value of $16,493.33. Following the completion of the transaction, the president now directly owns 596,241 shares […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.